SlideShare a Scribd company logo
FLUID &
ELECTROLYTE
THERAPY
Dr ARYA MOHAN
19-MVM-13
Body Fluids Water Solutes 2
TOTAL BODY WATER
60% of BW
ICF
(40%)
ECF (20%)
INTRAVAS
CULAR
FLUID
TRANSCEL
LULAR
FLUID
EXTRAVAS
CULAR
FLUID
INACCESSI
BLE BONE
FLUID
Blood
plasm
a
Interstitial
fluid
Lymph
Secretions from glandular
secretion, GI fluid, respiratory
fluid, CSF, aqueous humor,
peritoneal fluid
Electrolyte
 Compounds which exist as charged particles
in solution
 ECF contains mainly Na⁺ as major cation and
Cl⁻, HCO₃⁻ & HPO₄ 2⁻ as anions
 ICF contains K⁺ as major cation and HCO₃⁻,
PO₄ 3⁻, SO₄ 2⁻ & citrate as anions
 Electrolytes are essential for various life
processes
 ECF volume is mainly maintained by Na⁺ &
ICF volume is a function of K⁺ content-
maintained by Na⁺/K⁺ ATPase pumps
3
4
Acid-base balance
 Balance between acidity & alkalinity
 Determined by H⁺ ion concentration in various body
fluids
 pH of ECF is maintained within narrow limits of 40nEq
(pH-7.4) in arterial blood & 45nEq (pH- 7.35) in venous
blood & interstitial fluid
 Most enzymatic reactions have narrowly defined range
of pH optimum, a small variation in H⁺ ion will affect the
reaction rates & various biological processes
 pH of ECF above 7.8 & below 7.0 is incompatible with
life
 Normally a pH of arterial blood below 7.4 is considered
as acidosis/ acidemia & above 7.4 is considered as
5
H⁺ ion concentration is
maintained by
6
RESPIRATI
ON
RENAL
EXCRETION
CHEMICAL
BUFFER
Bicarbonate
buffer
Phosphate buffer
Protein buffer
7
DISTURBANCES IN WATER,
ELECTROLYTE & ACID-BASE
BALANCE
Water imbalance
DEHYDRATION
 Hypertonic- Water
loss with little or no
electrolyte loss
 Treated with
hypotonic solution
 Isotonic- Water loss
with proportionate
electrolyte loss
 Treated with
isotonic fluids
OVERHYDRATION
 Does not occur
commonly in animals
 Over hydration is
usually balanced
through renal water
excretion
 Treated with diuretics
8
ELECTROLYTE IMBALANCE 9
SODIUM
Hyponatre
mia
Hypernatre
mia
Hypovolemic hyponatremia
Hypervolemic hyponatremia
 Normovolemic
hyponatremia
Hypovolemic hypernatremia
Hypervolemic hypernatremia
 Normovolemic
hypernatremia
HYPONATREMIA
 Rapid in onset
 Acute hyponatremia
 Causes influx of water
into CNS
 Early signs include
lethargy, nausea &
vomiting
 More severe signs
include pulmonary &
cerebral edema, coma,
increase in body weight
 Seizures due to acute
water intoxication
 Clinical signs absent in
chronic loss of Na⁺
HYPERNATREMIA
 Related to cerebral
dehydration
 Depression, lethargy,
muscle rigidity, tremors,
myoclonus & hyper-
reflexia
 Vomiting, diarrhea,
polydipsia & polyuria
 Seizures, coma & death
in severe cases
10
CL
I
N
I
CA
L S
I
GN
S
HYPONATREMIA
 Severe symptomatic
hyponatremia-
hypertonic saline
solution (3-5% NaCl)
 Mild to moderate
hyponatremia- isotonic
saline solution (0.9%
NaCl)
 Adrenocortical
insufficiency – HRT
 Overhydrated patients-
hypertonic saline + loop
diuretics
 Normovolemic patients-
water restricted,
discontinue the AD
drugs
HYPERNATREMIA
 Hypermatremia with
pure water loss, water
is given orally or as
5% dextrose solution
 Hypotonic
hypernatremia treated
by 0.45% NaCl
solution or other
hypotonic fluids
 Hypertonic
hypernatremia- saline
solution + loop
diuretics
11
TR
EA
TM
EN
T
12
13
14
POTASSIUM
Hypokale
mia
Hyperkale
mia
Muscle weakness
Arrhythmia
Ileus
Rhabdomyolysis
Renal dysfunction
Reluctance or
inability to stand or
walk
Tremors
Bradycardia
Arrhythmia
HYPOKALEMIA
 Oral or parenteral
replacement
therapy
 KCl is preferred
solution (concurrent
alklaosis & Cl⁻
deficiency)
 K phosphate also
preferred; chance of
hyperphosphatemia
& hypocalcemia
 Should not
administer not more
than 0.5mEq/Kg/h iv
– fatal cardiotoxicity
HYPERKALEMIA
 Management of
underlying cause
 Withhold K⁺ rich foods
 Administer K⁺ free
fluids
 Na bicarbonate –
increase pH- push K⁺
into cells
 Ca slow iv- reduce
cardiotoxic effect
 Careful use of
diuretics
 Primary renal
disease- exchange
resins, peritoneal
dialysis &
hemodialysis
15
TR
EA
TM
EN
T
16
CHLORIDE
Hypochlor
emia
Hyperchlo
remia
0.9% NaCl (Saline
solution)
0.9% Saline solution
5% Dextrose water
17CALCIUM
Hypocalce
mia
Hypercalc
emia
MAGNESIUM
Hypomag
nesemia
Hypermagne
semia
PHOSPHOROUS
ACID BASE BALANCE
• RESPIRATOR
Y
• METABOLIC
ACIDOSIS
• RESPIRATOR
Y
• METABOLIC
ALKALOSI
S
18
19
Fluid therapy
 Therapy must be individualized & tailored to each
patient
 Constantly re-evaluated & reformulated according
to changes in status
 Fluid selection is dictated by
• Patient’s needs, including volume, rate, & fluid composition
required, as well as location the fluid is needed (interstitial
vs intravascular)
 Factors to consider include the following:
o Acute versus chronic conditions
o Patient pathology (e.g., acid-base balance, oncotic
pressure, electrolyte abnormalities)
o Comorbid conditions
20
Variety of conditions can be effectively
managed using three types of fluids:
 Balanced isotonic electrolyte (e.g.
crystalloid such as lactated Ringer’s
solution [LRS])
 Hypotonic solution (e.g. crystalloid such
as 5% dextrose in water [D5W])
 Synthetic colloid (e.g., hydroxyethyl
starch such as hetastarch or tetrastarch
21
General principles
Assess for the following three types
of fluid disturbances:
 Changes in volume (e.g., dehydration, blood
loss)
 Changes in content (e.g., hyperkalemia)
 Changes in distribution (e.g., pleural effusion)
22
 Type of fluid: - Choice of fluid depends on type
& extent of fluid losses incurred
 Balanced crystalloids are preferred when
replenishing hypovolemia in dehydrated patient
 Once rehydrated, maintenance solutions are
preferred for long term fluid therapy
 Amount of fluid needed: - maintenance need,
deficit & ongoing loss
Fluid requirement in 24 hrs = Maintenance
volume + Deficit (dehydrated) volume +
Ongoing losses
23
Maintenance
Volume
• Amount of
fluid normally
required over
a 24 h period
in a
dehydrated
animal
• 60mL/ Kg for
adults &
130mL/ Kg for
neonates
Deficit Volume
• Amount of
fluid already
lost by animal
during
disease
• Depends on
severity of
dehydration
Ongoing Fluid
Losses
• Loss of fluid
that is not
normal & is
continuing
during
treatment
period
• Loss of fluid
due to
vomiting,
diarrhea,
polyuria,
tachypnea,
24
Estimation of dehydration 25
classification 28
CRYSTALLOIDS
 Mostly Na based electrolyte solutions with or without
glucose in water
 Provide water, electrolyte, calorie & alkalising agents
 Effective both as maintenance & replacement
solutions
 Replacement Fluids
Mainly Na based fluids; have composition similar to
plasma; given rapidly in large volumes do not
drastically change constituents of intravascular fluids
 Maintenance Fluids
Used as normal substitutes for normal intake of water
& dietary electrolytes; provided after initial fluid
balance is restored
29
Saline solution
 Normal saline solution/ isotonic saline solution/ NaCl
solution/ Physiological Saline Solution
 Contains 0.9% w/v NaCl in water
 Most widely used replacement fluid; also used as
maintenance fluid
 Mildly acidic in nature
 ~ 300 mOsm/ Kg- isotonic with plasma; but not a
balanced fluid
 Replaces Na⁺ loss efficiently
 Can cause hyperchloremic metabolic alkalosis;
contains more Cl⁻ than that in plasma (diarrhea or
kidney unable to excrete excess Cl⁻)
 Contraindicated in patients with CHF & in restricted Na
intake
30
Hypertonic saline solution
 Available commercially as 3%, 5% & 7.5% w/v NaCl
in water
 Contain more osmotically active particles than
intracellular fluid, water moves from the interstitial
space
 Rapidly expand the plasma volume & help in
maintaining perfusion- hypovolemia & hemorrhagic
shock
 Indicated in hypervolemic hyponatremia, water
intoxication syndrome
 Provide mild positive inotropic effect & provide
pulmonary and systemic vasodilatation
 Contraindicated in dehydrated, hypernatremic or
hyperchloremic patients
 Should be administered slow iv (adverse cardiac
31
Hypotonic saline solution
 Contain 0.45% NaCl in water
 Contain NaCl half of that of isotonic saline –
Half Normal Saline Solution
 Osmolality less than that of ECF
 As maintenance fluid
 Along with 2.5% dextrose solution
32
Ringer solution
 Prototype of replacement fluids
 Contain Na, K, Ca & Cl in appropriate
concentrations
 Occasionally used as maintenance fluid
 High chloride content
 No bicarbonate precursor
33
Ringer lactate
 Hartmanns solution
 Ringer solution + lactate
 Ideal replacement fluid with plasma like electrolyte
composition
 Supplies bicarbonate ions after hepatic metabolism of
lactate
 Replacement of all fluid deficits & fluid delivery for all
shocks except cardiogenic shock
 Here Na lactate in ringer lactate is replaced by Na acetate
 Bicarbonate generation occurs in muscles & peripheral
tissues
34
Acetated ringers solution
 5% w/v dextrose in water
 Used a maintenance fluid & source of water
 Used in hypernatremia & primary water depletion states
 Should not be used as a replacement fluid
 Does not supply required electrolytes
 Not suitable for volume resuscitation, intravascular volume
maintenance or interstitial volume replacement
 For treatment of hypoglycemia & ketosis
 10%, 25% & 50% solutions
35Isotonic dextrose solution
hypertonic dextrose solution
Hypotonic dextrose solution
 2.5% w/v dextrose in water
 Used as maintenance fluid alone or in
combination with other fluids
 4.3% dextrose + 0.18% NaCl
 Maintenance of fluid & electrolyte levels
 Useful for hypertonic dehydration
36
isotonic dextrose solution
Sodium bicarbonate solution
 Treatment of metabolic acidosis
 1.5%, 5% & 8.4% solutions
 1.5% solution is approximately isotonic
 Used to alkalinise urine
 Adjunct in hypercalcemia & hyperkalemia
 Administered slowly – overshoot alkalosis
 Incompatible with D5W & D5 RL solutions
37
Potassium chloride solution
 Available as 2mEq/mL & 3mEq/mL solutions
 Treatment of hypokalemia
 Slow iv (rapid- cardiotoxic)
 Contraindicated in renal failure, AV block & hyperkalemia
 Diluted with 50 times its volume of 0.9% NaCl solution
 Mixtures of monobasic & dibasic salt forms
 To correct hypokalemia or hypophosphatemia diabetic ketoacidosis
38
Potassium phosphate solution
Calcium gluconate & calcium
borogluconate
 Most widely used salts of Ca
 Treatment of hypocalcemia in large & small animals
 Administered according to response of patient, intensity of
clinical signs & blood analysis
 Not preferred therapeutically
 More likely to cause hypotension
39
Calcium chloride
Magnesium sulphate
 Available in 10, 12.5, 25 & 50 concentrations
 Used as source of Mg in hypomagnesemic
tetany
 Overdosage cause CNS depression, cardiac
depression, respiratory depression & muscular
weakness
 Ventilatory support & Ca iv required for severe
hypermagnesimia
40
Darrow’s solution
 Lactated K saline injection
 Consists of 0.4% NaCl + 0.27% KCl + 0.58%
Na lactate
 Counters depletion of K in ICF in
dehydration
 Na lactate – alkalinising agent
 Less used in veterinary therapeutics
41
colloids
 Plasma volume expanders
 High molecular weight synthetic colloidal substances;
attract & hold water in vascular space
 Do not enhance O₂ carrying capacity of blood
 Natural colloids- plasma, albumin preparations & whole
blood
 Synthetic colloids are more readily available & carry no
risk of transmitting disease
 Effectiveness depends on molecular weight, colloid
content & bioavailability, their ability to bind
intravascular volume & maintain oncotic pressure
42
DESIRABLE PROPERTIES
 Should exert oncotic pressure comparable to
plasma
 Should remain in circulation for required period &
not readily leak out in tissues
 Pharmacologically inert
 Not pyrogenic or antigenic
 Not adversely affect any visceral organ
 Not interfere with grouping & cross matching of
blood
 Longer storage period
 Easily sterilisable
 Readily available & economical
43
 Useful in patients which are hypovolemic,
hypoproteinemic & shock
 Often in combination with hypertonic saline (to
increase effect of hypertonic saline & to reduce
the volume of crystalloids needed to achieve &
maintain adequate systemic arterial blood
pressure & tissue perfusion)
 Dextran, Hetastarch, Oxypolygelatine/ Gelatine
44
PLASMA
 Most commonly used colloid solution in
veterinary medicine
 Its main advantage stems from the colloid
osmotic pressure provided by plasma proteins
 It is useful for treating hypoproteinemic
conditions such as chronic liver disease,
protein-losing enteropathy, and glomerulopathy
 Main disadvantages of plasma are its limited
availability, its effects are temporary & it is
expensive
45
DEXTRANS
 Synthetic colloids derived from sugar beets
 Dextran 70 and 40 are available in 5% dextrose
or saline solutions
 Dextran 40 has the advantage of retarding
formation of rouleaux & sludging of RBC, thus
improving microcirculation above & beyond
simple volume expansion
 Disadvantages include coagulopathies as a
result of decreased platelet function & altered
fibrin clot formation
 Other problems include renal failure,
anaphylaxis & depressed immune function
46
HETASTARCH
 Hydroxyethyl starch (Hetastarch) is a synthetic
polymer derived from a waxy starch composed
mostly of amylopectin
 Like albumin, it expands the circulating plasma
volume
 Osmolality is approximately 310 mOsm/L
 expanded plasma volume may last for 24 hours
or longer
 Hydroxyethyl starch is available as a 6%
solution in saline
47
Oral rehydration solutions
 Essentially contain Na⁺, K⁺, Cl⁻ & glucose
 Widely used in man & small animals to correct water &
electrolyte loss due to diarrhea & other conditions
 Normally made isotonic
 Base- bicarbonate or citrate or lactate – to correct
acidosis
 Super ORS- ORS solution containing actively
transported amino acids (alanine & glycine)
48
49
50
SOME SPECIAL FLUID
THERAPY CONSIDERATIONS
ANEMIA
 Intravenous fluids are sometimes used
excessively in the anemic patient when the
decrease in red blood cell mass is
misinterpreted as total blood volume depletion,
when in fact the plasma volume might even be
expanded
 To compensate for decreased tissue oxygen
delivery, the heart rate increases, and if these
patients are subjected to large fluid volumes
over a short period of time, pulmonary edema
can occur
51
Extracellular Fluid Volume Excess
 Associated with an increase in total body salt & water
 Occurs in a variety of clinical settings including congestive
heart failure, glomerulopathies, liver fibrosis &protein-losing
enteropathyThese conditions are
 Associated with a decrease in "effective arterial volume,"
which stimulates the renin-angiotensin-aldosterone cycle &
the release of antidiuretic hormones to promote renal salt &
water retention
 Increased venous pressure from heart failure and cirrhosis
or because of decreased plasma oncotic pressure
associated with hypoalbuminemia, the retained salt and
water move into the interstitial and other body spaces,
causing edema, ascites, or pleural effusion
52
 Such patients are extremely sensitive to
intravenous overload with crystalloid solutions
 Treatment should be directed toward improving
the underlying primary pathologic process
 Fresh or fresh frozen plasma should be used to
volume expand animals with hypoalbuminemia,
although in glomerulopathies and protein-losing
enteropathy, beneficial effects are usually
temporary at best because of continued protein
losses
 Heart failure patients receiving intravenous fluids
should be closely observed for weight gain and
respiratory distress caused by intravascular fluid
overload
53
 When parenteral fluid therapy is indicated in
the cardiac patient, solutions containing little
or no sodium are given after dehydration
and hypovolemia are corrected with isotonic
solutions
 Either 0.45% saline or D-5-W can be used
 Efforts should be made to avoid
hypokalemia by adding potassium chloride
solution to the fluids at a dose of 7 to 10
mEq/250 ml
54
Hypovolemic Shock
 Isotonic crystalloid solutions (NS, acetated Ringer's or LRS)are the
most commonly used replacement fluids because they are usually
effective, readily available, easily administered, and relatively
inexpensive
 Severely hypotensive patients might require at least one whole
blood volume of replacement fluids during the first hour of
treatment
 Initial rapid infusion for dogs should be 20 to 40 ml/kg IV (one half
this amount for cats) for 15 minutes, followed by 70 to 90 ml/kg
(dogs) or 30 to 50 ml/kg (cats) administered over one hour
 Any signs of fluid overload necessitate prompt decreases in fluid
delivery and consideration of diuretic therapy
 Useful for treating dogs and cats with trauma-induced peracute
blood loss
 It has also been proved efficacious for treating other conditions in
which plasma volume is depleted rapidly, such as the canine
hemorrhagic gastroenteritis (HGE) syndrome
55
Vomiting
 Principle sign of gastric disease, but it can also accompany
disorders of the small or large bowel, liver, and pancreas, as well
as disorders occurring outside of the digestive system
 Deplete the body of a substantial volume of fluids and electrolytes
 Specific types of electrolyte deficiencies and acid-base
abnormalities depend on the location of the primary disorder
 Vomiting caused by pyloric outflow obstructions typically can lead
to dehydration, metabolic alkalosis, hypochloremia, hypokalemia,
and hyponatremia
 NS supplemented with potassium chloride (3 to 10
mEq/kgBW every 24-hours) is the fluid of choice
 Fluid losses through vomiting associated with systemic illness or
intestinal disease are best replaced with lactated or acetated
Ringer's solutions
56
Diarrhea
 Fluid deficit from massive diarrhea can be
efficiently corrected with LRS or acetated
Ringer's because
 In markedly hypotensive patients, the
intravenous fluids should be given as per
hypovolemic shock condition
57
ACIDOSIS
Respiratory
 Ventilation,
bronchodilators,
intubation
 Use of Na
bicarbonate is
contraindicated
 Chronic acidosis
is difficult to treat
Metabolic
 Correction of
primary
metabolic effect
 Use of
alkalinising
agents- NaHCO₃
58
ALKALOSIS
Respiratory
 Normalisation of
ventilation
 Removal of primary
cause
 O₂ therapy
 Mechanical
respirators
 Sedative or
tranquilisers if
needed
Metabolic
 Treat for primary cause
 Administration of Cl⁻-
Cl⁻ responsive alkalosis
 Correction of volume
depletion- 0.9% NaCl
solution
 KCl solution to treat
hypokalemia
 Ammonium chloride-
acidifying agents-
Hypochloremic alkalosis
59
60
THAN
K YOU

More Related Content

What's hot

Chest tube drainage
Chest tube drainageChest tube drainage
Chest tube drainage
Mahalakshmi Lakshmanan
 
14 peritoneal dialysis
14 peritoneal dialysis14 peritoneal dialysis
14 peritoneal dialysis
yogesh tiwari
 
blood transfusion ppt
blood transfusion pptblood transfusion ppt
blood transfusion ppt
Jennifer Savariau- Morris
 
Intravenous infusion
Intravenous infusionIntravenous infusion
Intravenous infusion
Nelson Munthali
 
Oxygen administration
Oxygen administrationOxygen administration
Oxygen administration
Francis K. Antwi
 
Bone marrow aspiration
Bone marrow aspirationBone marrow aspiration
Bone marrow aspiration
Dhini Balachandram
 
Epistaxis ( nose bleed)
Epistaxis ( nose bleed)Epistaxis ( nose bleed)
Epistaxis ( nose bleed)
pankaj rana
 
Intramuscular Injection or IM Injection
Intramuscular Injection or IM Injection Intramuscular Injection or IM Injection
Intramuscular Injection or IM Injection
Alam Nuzhathalam
 
Ear drops
Ear dropsEar drops
Ear drops
Manikandan T
 
Urinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing ManagementUrinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing Management
Swatilekha Das
 
Fluid and electrolyte imbalance
Fluid and electrolyte imbalanceFluid and electrolyte imbalance
Fluid and electrolyte imbalance
frank jc
 
Tracheostomy care
Tracheostomy careTracheostomy care
Tracheostomy care
THANUJA MATHEW
 
Bladder irrigation
Bladder irrigationBladder irrigation
Bladder irrigation
Assistant Professor
 
Bowel washing
Bowel washingBowel washing
Bowel washing
Atul Yadav
 
Assessing dehydration in children
Assessing dehydration in childrenAssessing dehydration in children
Assessing dehydration in children
Nursing Path
 
Care of patient with chest drainage system
Care of patient with chest drainage systemCare of patient with chest drainage system
Care of patient with chest drainage system
Siva Nanda Reddy
 
Hemodialysis
HemodialysisHemodialysis
Hemodialysis
Jinumol Jacob
 
Fracture and its nursing management
Fracture and its nursing managementFracture and its nursing management
Fracture and its nursing management
Durga Joshi
 
Hospitalization in children
Hospitalization in children Hospitalization in children
Hospitalization in children
raveen mayi
 
Calcium gluconate
Calcium gluconateCalcium gluconate
Calcium gluconate
Anubliss
 

What's hot (20)

Chest tube drainage
Chest tube drainageChest tube drainage
Chest tube drainage
 
14 peritoneal dialysis
14 peritoneal dialysis14 peritoneal dialysis
14 peritoneal dialysis
 
blood transfusion ppt
blood transfusion pptblood transfusion ppt
blood transfusion ppt
 
Intravenous infusion
Intravenous infusionIntravenous infusion
Intravenous infusion
 
Oxygen administration
Oxygen administrationOxygen administration
Oxygen administration
 
Bone marrow aspiration
Bone marrow aspirationBone marrow aspiration
Bone marrow aspiration
 
Epistaxis ( nose bleed)
Epistaxis ( nose bleed)Epistaxis ( nose bleed)
Epistaxis ( nose bleed)
 
Intramuscular Injection or IM Injection
Intramuscular Injection or IM Injection Intramuscular Injection or IM Injection
Intramuscular Injection or IM Injection
 
Ear drops
Ear dropsEar drops
Ear drops
 
Urinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing ManagementUrinary Tract Infection with Nursing Management
Urinary Tract Infection with Nursing Management
 
Fluid and electrolyte imbalance
Fluid and electrolyte imbalanceFluid and electrolyte imbalance
Fluid and electrolyte imbalance
 
Tracheostomy care
Tracheostomy careTracheostomy care
Tracheostomy care
 
Bladder irrigation
Bladder irrigationBladder irrigation
Bladder irrigation
 
Bowel washing
Bowel washingBowel washing
Bowel washing
 
Assessing dehydration in children
Assessing dehydration in childrenAssessing dehydration in children
Assessing dehydration in children
 
Care of patient with chest drainage system
Care of patient with chest drainage systemCare of patient with chest drainage system
Care of patient with chest drainage system
 
Hemodialysis
HemodialysisHemodialysis
Hemodialysis
 
Fracture and its nursing management
Fracture and its nursing managementFracture and its nursing management
Fracture and its nursing management
 
Hospitalization in children
Hospitalization in children Hospitalization in children
Hospitalization in children
 
Calcium gluconate
Calcium gluconateCalcium gluconate
Calcium gluconate
 

Similar to Fluid & electrolyte therapy

Different Type of Intravenous fluids
Different Type of Intravenous fluids Different Type of Intravenous fluids
Different Type of Intravenous fluids
NEHA MALIK
 
Principles of fluid therapy
Principles of fluid therapyPrinciples of fluid therapy
Principles of fluid therapy
KGMU LUCKNOW
 
Human excretory system for Nurses Class 2.pptx
Human excretory system for Nurses Class 2.pptxHuman excretory system for Nurses Class 2.pptx
Human excretory system for Nurses Class 2.pptx
JacobKurian22
 
FLUID &ELECTROLYTE.pptx
FLUID &ELECTROLYTE.pptxFLUID &ELECTROLYTE.pptx
FLUID &ELECTROLYTE.pptx
tsedalemekete1
 
Iv fluids
Iv fluidsIv fluids
Iv fluids
Dr. Tanmoy Roy
 
Fluid replacement therapy
Fluid replacement therapyFluid replacement therapy
Fluid replacement therapy
Sakina Rubab
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balance
Utkal University
 
Fluid And Electrolytes
Fluid And ElectrolytesFluid And Electrolytes
Fluid And Electrolytes
diamondeye
 
FLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptxFLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptx
FLOWERSOFPAKISTAN
 
24 fluid and electrolyte by mersha
24 fluid and electrolyte by mersha24 fluid and electrolyte by mersha
24 fluid and electrolyte by mersha
Engidaw Ambelu
 
Fluid and electrolyte balance lec 38
Fluid and electrolyte balance lec 38Fluid and electrolyte balance lec 38
Fluid and electrolyte balance lec 38
mariagul6
 
IV FLUIDS AND BLOOD IN RESUSCITATION
IV FLUIDS AND BLOOD IN RESUSCITATIONIV FLUIDS AND BLOOD IN RESUSCITATION
IV FLUIDS AND BLOOD IN RESUSCITATION
Ashray Vasanthapuram
 
Fluid And Electrolytes1
Fluid And Electrolytes1Fluid And Electrolytes1
Fluid And Electrolytes1
Dang Thanh Tuan
 
iv fluids NEW.pptx
iv fluids NEW.pptxiv fluids NEW.pptx
iv fluids NEW.pptx
almawali10
 
Lec 78
Lec 78Lec 78
Lec 78
mariagul7
 
Surgery 6th year, Tutorial (Dr. AbdulWahid)
Surgery 6th year, Tutorial (Dr. AbdulWahid)Surgery 6th year, Tutorial (Dr. AbdulWahid)
Surgery 6th year, Tutorial (Dr. AbdulWahid)
College of Medicine, Sulaymaniyah
 
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptxManagement-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
BatMan752678
 
FLUID & ELECTROLYTE IMBALANCE
FLUID & ELECTROLYTE IMBALANCEFLUID & ELECTROLYTE IMBALANCE
FLUID & ELECTROLYTE IMBALANCE
Flavia Dass
 
fluid balance.pptx
fluid balance.pptxfluid balance.pptx
fluid balance.pptx
hagiralhaj
 
Fluid therapy, fluid overload, complications pdf
Fluid therapy, fluid overload, complications pdfFluid therapy, fluid overload, complications pdf
Fluid therapy, fluid overload, complications pdf
SrishtiGupta177
 

Similar to Fluid & electrolyte therapy (20)

Different Type of Intravenous fluids
Different Type of Intravenous fluids Different Type of Intravenous fluids
Different Type of Intravenous fluids
 
Principles of fluid therapy
Principles of fluid therapyPrinciples of fluid therapy
Principles of fluid therapy
 
Human excretory system for Nurses Class 2.pptx
Human excretory system for Nurses Class 2.pptxHuman excretory system for Nurses Class 2.pptx
Human excretory system for Nurses Class 2.pptx
 
FLUID &ELECTROLYTE.pptx
FLUID &ELECTROLYTE.pptxFLUID &ELECTROLYTE.pptx
FLUID &ELECTROLYTE.pptx
 
Iv fluids
Iv fluidsIv fluids
Iv fluids
 
Fluid replacement therapy
Fluid replacement therapyFluid replacement therapy
Fluid replacement therapy
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balance
 
Fluid And Electrolytes
Fluid And ElectrolytesFluid And Electrolytes
Fluid And Electrolytes
 
FLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptxFLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptx
 
24 fluid and electrolyte by mersha
24 fluid and electrolyte by mersha24 fluid and electrolyte by mersha
24 fluid and electrolyte by mersha
 
Fluid and electrolyte balance lec 38
Fluid and electrolyte balance lec 38Fluid and electrolyte balance lec 38
Fluid and electrolyte balance lec 38
 
IV FLUIDS AND BLOOD IN RESUSCITATION
IV FLUIDS AND BLOOD IN RESUSCITATIONIV FLUIDS AND BLOOD IN RESUSCITATION
IV FLUIDS AND BLOOD IN RESUSCITATION
 
Fluid And Electrolytes1
Fluid And Electrolytes1Fluid And Electrolytes1
Fluid And Electrolytes1
 
iv fluids NEW.pptx
iv fluids NEW.pptxiv fluids NEW.pptx
iv fluids NEW.pptx
 
Lec 78
Lec 78Lec 78
Lec 78
 
Surgery 6th year, Tutorial (Dr. AbdulWahid)
Surgery 6th year, Tutorial (Dr. AbdulWahid)Surgery 6th year, Tutorial (Dr. AbdulWahid)
Surgery 6th year, Tutorial (Dr. AbdulWahid)
 
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptxManagement-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
Management-of-IV-Fluids-and-Electrolyte-Balance-slides.pptx
 
FLUID & ELECTROLYTE IMBALANCE
FLUID & ELECTROLYTE IMBALANCEFLUID & ELECTROLYTE IMBALANCE
FLUID & ELECTROLYTE IMBALANCE
 
fluid balance.pptx
fluid balance.pptxfluid balance.pptx
fluid balance.pptx
 
Fluid therapy, fluid overload, complications pdf
Fluid therapy, fluid overload, complications pdfFluid therapy, fluid overload, complications pdf
Fluid therapy, fluid overload, complications pdf
 

Recently uploaded

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 

Recently uploaded (20)

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 

Fluid & electrolyte therapy

  • 2. Body Fluids Water Solutes 2 TOTAL BODY WATER 60% of BW ICF (40%) ECF (20%) INTRAVAS CULAR FLUID TRANSCEL LULAR FLUID EXTRAVAS CULAR FLUID INACCESSI BLE BONE FLUID Blood plasm a Interstitial fluid Lymph Secretions from glandular secretion, GI fluid, respiratory fluid, CSF, aqueous humor, peritoneal fluid
  • 3. Electrolyte  Compounds which exist as charged particles in solution  ECF contains mainly Na⁺ as major cation and Cl⁻, HCO₃⁻ & HPO₄ 2⁻ as anions  ICF contains K⁺ as major cation and HCO₃⁻, PO₄ 3⁻, SO₄ 2⁻ & citrate as anions  Electrolytes are essential for various life processes  ECF volume is mainly maintained by Na⁺ & ICF volume is a function of K⁺ content- maintained by Na⁺/K⁺ ATPase pumps 3
  • 4. 4
  • 5. Acid-base balance  Balance between acidity & alkalinity  Determined by H⁺ ion concentration in various body fluids  pH of ECF is maintained within narrow limits of 40nEq (pH-7.4) in arterial blood & 45nEq (pH- 7.35) in venous blood & interstitial fluid  Most enzymatic reactions have narrowly defined range of pH optimum, a small variation in H⁺ ion will affect the reaction rates & various biological processes  pH of ECF above 7.8 & below 7.0 is incompatible with life  Normally a pH of arterial blood below 7.4 is considered as acidosis/ acidemia & above 7.4 is considered as 5
  • 6. H⁺ ion concentration is maintained by 6 RESPIRATI ON RENAL EXCRETION CHEMICAL BUFFER Bicarbonate buffer Phosphate buffer Protein buffer
  • 8. Water imbalance DEHYDRATION  Hypertonic- Water loss with little or no electrolyte loss  Treated with hypotonic solution  Isotonic- Water loss with proportionate electrolyte loss  Treated with isotonic fluids OVERHYDRATION  Does not occur commonly in animals  Over hydration is usually balanced through renal water excretion  Treated with diuretics 8
  • 9. ELECTROLYTE IMBALANCE 9 SODIUM Hyponatre mia Hypernatre mia Hypovolemic hyponatremia Hypervolemic hyponatremia  Normovolemic hyponatremia Hypovolemic hypernatremia Hypervolemic hypernatremia  Normovolemic hypernatremia
  • 10. HYPONATREMIA  Rapid in onset  Acute hyponatremia  Causes influx of water into CNS  Early signs include lethargy, nausea & vomiting  More severe signs include pulmonary & cerebral edema, coma, increase in body weight  Seizures due to acute water intoxication  Clinical signs absent in chronic loss of Na⁺ HYPERNATREMIA  Related to cerebral dehydration  Depression, lethargy, muscle rigidity, tremors, myoclonus & hyper- reflexia  Vomiting, diarrhea, polydipsia & polyuria  Seizures, coma & death in severe cases 10 CL I N I CA L S I GN S
  • 11. HYPONATREMIA  Severe symptomatic hyponatremia- hypertonic saline solution (3-5% NaCl)  Mild to moderate hyponatremia- isotonic saline solution (0.9% NaCl)  Adrenocortical insufficiency – HRT  Overhydrated patients- hypertonic saline + loop diuretics  Normovolemic patients- water restricted, discontinue the AD drugs HYPERNATREMIA  Hypermatremia with pure water loss, water is given orally or as 5% dextrose solution  Hypotonic hypernatremia treated by 0.45% NaCl solution or other hypotonic fluids  Hypertonic hypernatremia- saline solution + loop diuretics 11 TR EA TM EN T
  • 12. 12
  • 13. 13
  • 15. HYPOKALEMIA  Oral or parenteral replacement therapy  KCl is preferred solution (concurrent alklaosis & Cl⁻ deficiency)  K phosphate also preferred; chance of hyperphosphatemia & hypocalcemia  Should not administer not more than 0.5mEq/Kg/h iv – fatal cardiotoxicity HYPERKALEMIA  Management of underlying cause  Withhold K⁺ rich foods  Administer K⁺ free fluids  Na bicarbonate – increase pH- push K⁺ into cells  Ca slow iv- reduce cardiotoxic effect  Careful use of diuretics  Primary renal disease- exchange resins, peritoneal dialysis & hemodialysis 15 TR EA TM EN T
  • 18. ACID BASE BALANCE • RESPIRATOR Y • METABOLIC ACIDOSIS • RESPIRATOR Y • METABOLIC ALKALOSI S 18
  • 19. 19
  • 20. Fluid therapy  Therapy must be individualized & tailored to each patient  Constantly re-evaluated & reformulated according to changes in status  Fluid selection is dictated by • Patient’s needs, including volume, rate, & fluid composition required, as well as location the fluid is needed (interstitial vs intravascular)  Factors to consider include the following: o Acute versus chronic conditions o Patient pathology (e.g., acid-base balance, oncotic pressure, electrolyte abnormalities) o Comorbid conditions 20
  • 21. Variety of conditions can be effectively managed using three types of fluids:  Balanced isotonic electrolyte (e.g. crystalloid such as lactated Ringer’s solution [LRS])  Hypotonic solution (e.g. crystalloid such as 5% dextrose in water [D5W])  Synthetic colloid (e.g., hydroxyethyl starch such as hetastarch or tetrastarch 21
  • 22. General principles Assess for the following three types of fluid disturbances:  Changes in volume (e.g., dehydration, blood loss)  Changes in content (e.g., hyperkalemia)  Changes in distribution (e.g., pleural effusion) 22
  • 23.  Type of fluid: - Choice of fluid depends on type & extent of fluid losses incurred  Balanced crystalloids are preferred when replenishing hypovolemia in dehydrated patient  Once rehydrated, maintenance solutions are preferred for long term fluid therapy  Amount of fluid needed: - maintenance need, deficit & ongoing loss Fluid requirement in 24 hrs = Maintenance volume + Deficit (dehydrated) volume + Ongoing losses 23
  • 24. Maintenance Volume • Amount of fluid normally required over a 24 h period in a dehydrated animal • 60mL/ Kg for adults & 130mL/ Kg for neonates Deficit Volume • Amount of fluid already lost by animal during disease • Depends on severity of dehydration Ongoing Fluid Losses • Loss of fluid that is not normal & is continuing during treatment period • Loss of fluid due to vomiting, diarrhea, polyuria, tachypnea, 24
  • 26.
  • 27.
  • 29. CRYSTALLOIDS  Mostly Na based electrolyte solutions with or without glucose in water  Provide water, electrolyte, calorie & alkalising agents  Effective both as maintenance & replacement solutions  Replacement Fluids Mainly Na based fluids; have composition similar to plasma; given rapidly in large volumes do not drastically change constituents of intravascular fluids  Maintenance Fluids Used as normal substitutes for normal intake of water & dietary electrolytes; provided after initial fluid balance is restored 29
  • 30. Saline solution  Normal saline solution/ isotonic saline solution/ NaCl solution/ Physiological Saline Solution  Contains 0.9% w/v NaCl in water  Most widely used replacement fluid; also used as maintenance fluid  Mildly acidic in nature  ~ 300 mOsm/ Kg- isotonic with plasma; but not a balanced fluid  Replaces Na⁺ loss efficiently  Can cause hyperchloremic metabolic alkalosis; contains more Cl⁻ than that in plasma (diarrhea or kidney unable to excrete excess Cl⁻)  Contraindicated in patients with CHF & in restricted Na intake 30
  • 31. Hypertonic saline solution  Available commercially as 3%, 5% & 7.5% w/v NaCl in water  Contain more osmotically active particles than intracellular fluid, water moves from the interstitial space  Rapidly expand the plasma volume & help in maintaining perfusion- hypovolemia & hemorrhagic shock  Indicated in hypervolemic hyponatremia, water intoxication syndrome  Provide mild positive inotropic effect & provide pulmonary and systemic vasodilatation  Contraindicated in dehydrated, hypernatremic or hyperchloremic patients  Should be administered slow iv (adverse cardiac 31
  • 32. Hypotonic saline solution  Contain 0.45% NaCl in water  Contain NaCl half of that of isotonic saline – Half Normal Saline Solution  Osmolality less than that of ECF  As maintenance fluid  Along with 2.5% dextrose solution 32
  • 33. Ringer solution  Prototype of replacement fluids  Contain Na, K, Ca & Cl in appropriate concentrations  Occasionally used as maintenance fluid  High chloride content  No bicarbonate precursor 33
  • 34. Ringer lactate  Hartmanns solution  Ringer solution + lactate  Ideal replacement fluid with plasma like electrolyte composition  Supplies bicarbonate ions after hepatic metabolism of lactate  Replacement of all fluid deficits & fluid delivery for all shocks except cardiogenic shock  Here Na lactate in ringer lactate is replaced by Na acetate  Bicarbonate generation occurs in muscles & peripheral tissues 34 Acetated ringers solution
  • 35.  5% w/v dextrose in water  Used a maintenance fluid & source of water  Used in hypernatremia & primary water depletion states  Should not be used as a replacement fluid  Does not supply required electrolytes  Not suitable for volume resuscitation, intravascular volume maintenance or interstitial volume replacement  For treatment of hypoglycemia & ketosis  10%, 25% & 50% solutions 35Isotonic dextrose solution hypertonic dextrose solution
  • 36. Hypotonic dextrose solution  2.5% w/v dextrose in water  Used as maintenance fluid alone or in combination with other fluids  4.3% dextrose + 0.18% NaCl  Maintenance of fluid & electrolyte levels  Useful for hypertonic dehydration 36 isotonic dextrose solution
  • 37. Sodium bicarbonate solution  Treatment of metabolic acidosis  1.5%, 5% & 8.4% solutions  1.5% solution is approximately isotonic  Used to alkalinise urine  Adjunct in hypercalcemia & hyperkalemia  Administered slowly – overshoot alkalosis  Incompatible with D5W & D5 RL solutions 37
  • 38. Potassium chloride solution  Available as 2mEq/mL & 3mEq/mL solutions  Treatment of hypokalemia  Slow iv (rapid- cardiotoxic)  Contraindicated in renal failure, AV block & hyperkalemia  Diluted with 50 times its volume of 0.9% NaCl solution  Mixtures of monobasic & dibasic salt forms  To correct hypokalemia or hypophosphatemia diabetic ketoacidosis 38 Potassium phosphate solution
  • 39. Calcium gluconate & calcium borogluconate  Most widely used salts of Ca  Treatment of hypocalcemia in large & small animals  Administered according to response of patient, intensity of clinical signs & blood analysis  Not preferred therapeutically  More likely to cause hypotension 39 Calcium chloride
  • 40. Magnesium sulphate  Available in 10, 12.5, 25 & 50 concentrations  Used as source of Mg in hypomagnesemic tetany  Overdosage cause CNS depression, cardiac depression, respiratory depression & muscular weakness  Ventilatory support & Ca iv required for severe hypermagnesimia 40
  • 41. Darrow’s solution  Lactated K saline injection  Consists of 0.4% NaCl + 0.27% KCl + 0.58% Na lactate  Counters depletion of K in ICF in dehydration  Na lactate – alkalinising agent  Less used in veterinary therapeutics 41
  • 42. colloids  Plasma volume expanders  High molecular weight synthetic colloidal substances; attract & hold water in vascular space  Do not enhance O₂ carrying capacity of blood  Natural colloids- plasma, albumin preparations & whole blood  Synthetic colloids are more readily available & carry no risk of transmitting disease  Effectiveness depends on molecular weight, colloid content & bioavailability, their ability to bind intravascular volume & maintain oncotic pressure 42
  • 43. DESIRABLE PROPERTIES  Should exert oncotic pressure comparable to plasma  Should remain in circulation for required period & not readily leak out in tissues  Pharmacologically inert  Not pyrogenic or antigenic  Not adversely affect any visceral organ  Not interfere with grouping & cross matching of blood  Longer storage period  Easily sterilisable  Readily available & economical 43
  • 44.  Useful in patients which are hypovolemic, hypoproteinemic & shock  Often in combination with hypertonic saline (to increase effect of hypertonic saline & to reduce the volume of crystalloids needed to achieve & maintain adequate systemic arterial blood pressure & tissue perfusion)  Dextran, Hetastarch, Oxypolygelatine/ Gelatine 44
  • 45. PLASMA  Most commonly used colloid solution in veterinary medicine  Its main advantage stems from the colloid osmotic pressure provided by plasma proteins  It is useful for treating hypoproteinemic conditions such as chronic liver disease, protein-losing enteropathy, and glomerulopathy  Main disadvantages of plasma are its limited availability, its effects are temporary & it is expensive 45
  • 46. DEXTRANS  Synthetic colloids derived from sugar beets  Dextran 70 and 40 are available in 5% dextrose or saline solutions  Dextran 40 has the advantage of retarding formation of rouleaux & sludging of RBC, thus improving microcirculation above & beyond simple volume expansion  Disadvantages include coagulopathies as a result of decreased platelet function & altered fibrin clot formation  Other problems include renal failure, anaphylaxis & depressed immune function 46
  • 47. HETASTARCH  Hydroxyethyl starch (Hetastarch) is a synthetic polymer derived from a waxy starch composed mostly of amylopectin  Like albumin, it expands the circulating plasma volume  Osmolality is approximately 310 mOsm/L  expanded plasma volume may last for 24 hours or longer  Hydroxyethyl starch is available as a 6% solution in saline 47
  • 48. Oral rehydration solutions  Essentially contain Na⁺, K⁺, Cl⁻ & glucose  Widely used in man & small animals to correct water & electrolyte loss due to diarrhea & other conditions  Normally made isotonic  Base- bicarbonate or citrate or lactate – to correct acidosis  Super ORS- ORS solution containing actively transported amino acids (alanine & glycine) 48
  • 49. 49
  • 51. ANEMIA  Intravenous fluids are sometimes used excessively in the anemic patient when the decrease in red blood cell mass is misinterpreted as total blood volume depletion, when in fact the plasma volume might even be expanded  To compensate for decreased tissue oxygen delivery, the heart rate increases, and if these patients are subjected to large fluid volumes over a short period of time, pulmonary edema can occur 51
  • 52. Extracellular Fluid Volume Excess  Associated with an increase in total body salt & water  Occurs in a variety of clinical settings including congestive heart failure, glomerulopathies, liver fibrosis &protein-losing enteropathyThese conditions are  Associated with a decrease in "effective arterial volume," which stimulates the renin-angiotensin-aldosterone cycle & the release of antidiuretic hormones to promote renal salt & water retention  Increased venous pressure from heart failure and cirrhosis or because of decreased plasma oncotic pressure associated with hypoalbuminemia, the retained salt and water move into the interstitial and other body spaces, causing edema, ascites, or pleural effusion 52
  • 53.  Such patients are extremely sensitive to intravenous overload with crystalloid solutions  Treatment should be directed toward improving the underlying primary pathologic process  Fresh or fresh frozen plasma should be used to volume expand animals with hypoalbuminemia, although in glomerulopathies and protein-losing enteropathy, beneficial effects are usually temporary at best because of continued protein losses  Heart failure patients receiving intravenous fluids should be closely observed for weight gain and respiratory distress caused by intravascular fluid overload 53
  • 54.  When parenteral fluid therapy is indicated in the cardiac patient, solutions containing little or no sodium are given after dehydration and hypovolemia are corrected with isotonic solutions  Either 0.45% saline or D-5-W can be used  Efforts should be made to avoid hypokalemia by adding potassium chloride solution to the fluids at a dose of 7 to 10 mEq/250 ml 54
  • 55. Hypovolemic Shock  Isotonic crystalloid solutions (NS, acetated Ringer's or LRS)are the most commonly used replacement fluids because they are usually effective, readily available, easily administered, and relatively inexpensive  Severely hypotensive patients might require at least one whole blood volume of replacement fluids during the first hour of treatment  Initial rapid infusion for dogs should be 20 to 40 ml/kg IV (one half this amount for cats) for 15 minutes, followed by 70 to 90 ml/kg (dogs) or 30 to 50 ml/kg (cats) administered over one hour  Any signs of fluid overload necessitate prompt decreases in fluid delivery and consideration of diuretic therapy  Useful for treating dogs and cats with trauma-induced peracute blood loss  It has also been proved efficacious for treating other conditions in which plasma volume is depleted rapidly, such as the canine hemorrhagic gastroenteritis (HGE) syndrome 55
  • 56. Vomiting  Principle sign of gastric disease, but it can also accompany disorders of the small or large bowel, liver, and pancreas, as well as disorders occurring outside of the digestive system  Deplete the body of a substantial volume of fluids and electrolytes  Specific types of electrolyte deficiencies and acid-base abnormalities depend on the location of the primary disorder  Vomiting caused by pyloric outflow obstructions typically can lead to dehydration, metabolic alkalosis, hypochloremia, hypokalemia, and hyponatremia  NS supplemented with potassium chloride (3 to 10 mEq/kgBW every 24-hours) is the fluid of choice  Fluid losses through vomiting associated with systemic illness or intestinal disease are best replaced with lactated or acetated Ringer's solutions 56
  • 57. Diarrhea  Fluid deficit from massive diarrhea can be efficiently corrected with LRS or acetated Ringer's because  In markedly hypotensive patients, the intravenous fluids should be given as per hypovolemic shock condition 57
  • 58. ACIDOSIS Respiratory  Ventilation, bronchodilators, intubation  Use of Na bicarbonate is contraindicated  Chronic acidosis is difficult to treat Metabolic  Correction of primary metabolic effect  Use of alkalinising agents- NaHCO₃ 58
  • 59. ALKALOSIS Respiratory  Normalisation of ventilation  Removal of primary cause  O₂ therapy  Mechanical respirators  Sedative or tranquilisers if needed Metabolic  Treat for primary cause  Administration of Cl⁻- Cl⁻ responsive alkalosis  Correction of volume depletion- 0.9% NaCl solution  KCl solution to treat hypokalemia  Ammonium chloride- acidifying agents- Hypochloremic alkalosis 59